Skip to main content

Astrocyte Pharmaceuticals

Cambridge, United States

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

$6.0M raised
Aug 2023
Series B

Top Investors

DeepWork CapitalNational Institutes of HealthNavis Capital PartnersAlzheimer's Drug Discovery FoundationBrightFocus Foundation

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Astrocyte Pharmaceuticals

How much funding has Astrocyte Pharmaceuticals raised?
Astrocyte Pharmaceuticals has raised $6.0M in total funding. The most recent round was Series B. The last funding was announced in August 2023.
Who are Astrocyte Pharmaceuticals's investors?
Astrocyte Pharmaceuticals's investors include DeepWork Capital, National Institutes of Health, Navis Capital Partners, Alzheimer's Drug Discovery Foundation, BrightFocus Foundation.
Where is Astrocyte Pharmaceuticals headquartered?
Astrocyte Pharmaceuticals is headquartered in Cambridge, United States.
What does Astrocyte Pharmaceuticals do?
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
What stage is Astrocyte Pharmaceuticals at?
Astrocyte Pharmaceuticals is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Astrocyte Pharmaceuticals — Funding & Investors." VCBacked, August 18, 2023, https://www.vcbacked.co/company/astrocyte-pharmaceuticals. Accessed June 4, 2026.
APA
VCBacked. (2023). Astrocyte Pharmaceuticals — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/astrocyte-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Astrocyte Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/astrocyte-pharmaceuticals |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .